147 related articles for article (PubMed ID: 21761940)
21. Theoretical study of the human bradykinin-bradykinin B2 receptor complex.
Gieldon A; Lopez JJ; Glaubitz C; Schwalbe H
Chembiochem; 2008 Oct; 9(15):2487-97. PubMed ID: 18803210
[TBL] [Abstract][Full Text] [Related]
22. The use of biosensor technology for the engineering of antibodies and enzymes.
Huber A; Demartis S; Neri D
J Mol Recognit; 1999; 12(3):198-216. PubMed ID: 10398410
[TBL] [Abstract][Full Text] [Related]
23. Alanine screening of the intracellular loops of the human bradykinin B receptor--effects on receptor maintenance, G protein activation and internalization.
Faussner A; Wennerberg G; Schüssler S; Feierler J; Seidl C; Jochum M; Proud D
FEBS J; 2009 Jul; 276(13):3491-503. PubMed ID: 19456859
[TBL] [Abstract][Full Text] [Related]
24. Ligand-directed acyl imidazole chemistry for labeling of membrane-bound proteins on live cells.
Fujishima SH; Yasui R; Miki T; Ojida A; Hamachi I
J Am Chem Soc; 2012 Mar; 134(9):3961-4. PubMed ID: 22352855
[TBL] [Abstract][Full Text] [Related]
25. A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures.
Annis DA; Nazef N; Chuang CC; Scott MP; Nash HM
J Am Chem Soc; 2004 Dec; 126(47):15495-503. PubMed ID: 15563178
[TBL] [Abstract][Full Text] [Related]
26. Effects of clustered epitopes in multivalent ligand-receptor interactions.
Dam TK; Brewer CF
Biochemistry; 2008 Aug; 47(33):8470-6. PubMed ID: 18652478
[TBL] [Abstract][Full Text] [Related]
27. Fluorescent ligands of the bradykinin B1 receptors: pharmacologic characterization and application to the study of agonist-induced receptor translocation and cell surface receptor expression.
Bawolak MT; Gera L; Morissette G; Bouthillier J; Stewart JM; Gobeil LA; Lodge R; Adam A; Marceau F
J Pharmacol Exp Ther; 2009 Apr; 329(1):159-68. PubMed ID: 19136639
[TBL] [Abstract][Full Text] [Related]
28. 4-(N,N-dimethylamino)pyridine-embedded nanoporous conjugated polymer as a highly active heterogeneous organocatalyst.
Zhang Y; Zhang Y; Sun YL; Du X; Shi JY; Wang WD; Wang W
Chemistry; 2012 May; 18(20):6328-34. PubMed ID: 22467297
[TBL] [Abstract][Full Text] [Related]
29. Chiral N,N'-dioxides: new ligands and organocatalysts for catalytic asymmetric reactions.
Liu X; Lin L; Feng X
Acc Chem Res; 2011 Aug; 44(8):574-87. PubMed ID: 21702458
[TBL] [Abstract][Full Text] [Related]
30. Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells.
Patnaik SK; Potvin B; Carlsson S; Sturm D; Leffler H; Stanley P
Glycobiology; 2006 Apr; 16(4):305-17. PubMed ID: 16319083
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and characterization of the first fluorescent nonpeptide NPY Y1 receptor antagonist.
Schneider E; Keller M; Brennauer A; Hoefelschweiger BK; Gross D; Wolfbeis OS; Bernhardt G; Buschauer A
Chembiochem; 2007 Nov; 8(16):1981-8. PubMed ID: 17876753
[TBL] [Abstract][Full Text] [Related]
32. EP24.15 interacts with the angiotensin II type I receptor and bradykinin B2 receptor.
Shivakumar BR; Wang Z; Hammond TG; Harris RC
Cell Biochem Funct; 2005; 23(3):195-204. PubMed ID: 15376229
[TBL] [Abstract][Full Text] [Related]
33. Analysis of Cell-Surface Receptor Dynamics through Covalent Labeling by Catalyst-Tethered Antibody.
Hayashi T; Yasueda Y; Tamura T; Takaoka Y; Hamachi I
J Am Chem Soc; 2015 Apr; 137(16):5372-80. PubMed ID: 25853648
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of sequestration of human B2 bradykinin receptor by phenylarsine oxide or sucrose allows determination of a receptor affinity shift and ligand dissociation in intact cells.
Faussner A; Schuessler S; Seidl C; Jochum M
Biol Chem; 2004 Sep; 385(9):835-43. PubMed ID: 15493879
[TBL] [Abstract][Full Text] [Related]
35. Bioactivity-guided navigation of chemical space.
Bon RS; Waldmann H
Acc Chem Res; 2010 Aug; 43(8):1103-14. PubMed ID: 20481515
[TBL] [Abstract][Full Text] [Related]
36. Merging nucleophilic and hydrogen bonding catalysis: an anion binding approach to the kinetic resolution of propargylic amines.
Klauber EG; De CK; Shah TK; Seidel D
J Am Chem Soc; 2010 Oct; 132(39):13624-6. PubMed ID: 20843041
[TBL] [Abstract][Full Text] [Related]
37. In situ evaluation of kinetic resolution catalysts for nitroaldol by rationally designed fluorescence probe.
Matsumoto T; Urano Y; Takahashi Y; Mori Y; Terai T; Nagano T
J Org Chem; 2011 May; 76(10):3616-25. PubMed ID: 21370849
[TBL] [Abstract][Full Text] [Related]
38. Functional role of the conserved proline in helix 6 of the human bradykinin B2 receptor.
Haffemayer B; Richard E; Mattras H; Marie J
Biochem Biophys Res Commun; 2008 Feb; 366(4):1001-6. PubMed ID: 18096516
[TBL] [Abstract][Full Text] [Related]
39. Activation of ERK, JNK, Akt, and G-protein coupled signaling by hybrid angiotensin II AT1/bradykinin B2 receptors expressed in HEK-293 cells.
Yu J; Lubinsky D; Tsomaia N; Huang Z; Taylor L; Mierke D; Navarro J; Miraz O; Polgar P
J Cell Biochem; 2007 May; 101(1):192-204. PubMed ID: 17212359
[TBL] [Abstract][Full Text] [Related]
40. Discovery and characterization of orthosteric and allosteric muscarinic M2 acetylcholine receptor ligands by affinity selection-mass spectrometry.
Whitehurst CE; Nazef N; Annis DA; Hou Y; Murphy DM; Spacciapoli P; Yao Z; Ziebell MR; Cheng CC; Shipps GW; Felsch JS; Lau D; Nash HM
J Biomol Screen; 2006 Mar; 11(2):194-207. PubMed ID: 16490772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
